COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,280 Articles (22,759 medRxiv, 8,521 bioRxiv)

Most recent first Previous |  Page 382: Articles 3811-3820  | Next

The Impact of the UK COVID-19 Lockdown on the Screening, Diagnostics and Incidence of Breast, Colorectal, Lung and Prostate Cancer in the UK: a Population-Based Cohort Study
Barclay, N. L., Pineda-Moncusi, M. L., Jodicke, A. M., Prieto-Alhambra, D., Raventos, B., Newby, D., Delmestri, A., Man, W. Y., Chen, X., Catala, M.
10.1101/2023.07.21.23292937 — Posted: 2023-07-26
Non-neutralizing SARS-CoV-2 N-terminal domain antibodies protect mice against severe disease using Fc-mediated effector functions
Pierre, C. N., Adams, L. E., Anasti, K., Goodman, D., Stanfield-Oakley, S., Powers, J. M., Li, D., Rountree, W., Wang, Y., Edwards, R. J., Alam, S. M., Ferrari, G., Tomaras, G. D., Haynes, B. F., Baric, R. S., Saunders, K.
10.1101/2023.07.25.550460 — Posted: 2023-07-26
Experimental infection of elk (Cervus canadensis) and mule deer (Odocoileus hemionus) with SARS-CoV-2
Porter, S. M., Hartwig, A. E., Bielefeldt-Ohmann, H., Root, J., Bosco-Lauth, A.
10.1101/2023.07.25.550568 — Posted: 2023-07-26
A low-cost molecular test for SARS-CoV-2 detection suitable for variant discrimination and community testing using saliva
Silva, S. M., Amaral, C., Luis, C., Grilo, D., Duarte, A., Morais, I., Afonso, G., Faria, N., Antunes, W., Gomes, I., Sa-Leao, R., Miragaia, M., Serrano, M., Pimentel, C.
10.1101/2023.07.20.23292863 — Posted: 2023-07-25
Quantification of Covid-19 Vaccine Coercion in India: A Survey Study
Raman, B., Banerjee, A., Vajjala, S. M.
10.1101/2023.07.24.23293089 — Posted: 2023-07-25
Mammalian cells-based platforms for the generation of SARS-CoV-2 virus-like particles
Elfayres, G., Paswan, R. R., Sika, L., Girard, M.-P., Khalfi, S., Letanneur, C., Milette, K., Singh, A., Kobinger, G., Berthoux, L.
10.1101/2023.07.24.550415 — Posted: 2023-07-25
Predictive Systems Biology Modeling: Unraveling Host Metabolic Disruptions and Potential Drug Targets in SARS-CoV-2 and Its Variants
Li, G.-H., Han, F., Luo, R.-H., Li, P., Chang, C.-J., Xu, W., Long, X.-Y., Huang, J.-F., Zheng, Y.-T., Kong, Q.-P., Xiao, W.
10.1101/2023.07.24.550423 — Posted: 2023-07-25
Factors influencing COVID-19 vaccination decision-making among African American and Hispanic pregnant and postpartum women in Deep South
Zhang, R., Byrd, T., Qiao, S., Torres, M. E., Li, X., Liu, J.
10.1101/2023.07.20.23292951 — Posted: 2023-07-24
The Role of the Tyrosine-Based Sorting Signals of the ORF3a Protein of SARS-CoV-2 on Intracellular Trafficking, Autophagy, and Apoptosis
Stephens, E. B., Henke, W., Kalamvoki, M.
10.1101/2023.07.24.550379 — Posted: 2023-07-24
Revealing and evaluation of antivirals targeting multiple druggable sites of RdRp complex in SARS-CoV-2
Rani, R., Nehul, S., Choudhary, S., Upadhyay, A., Sharma, G. K., Kumar, P., Tomar, S.
10.1101/2023.07.24.550324 — Posted: 2023-07-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).